Liraglutide counteracts obesity and glucose intolerance in a mouse model of glucocorticoid-induced metabolic syndrome

BACKGROUND: Glucocorticoid excess is commonly associated with diabetogenic effects, including insulin resistance and glucose intolerance. The effects of the long-term glucagon-like peptide 1 receptor agonist treatment on the metabolic syndrome-like conditions are not yet fully elucidated. Thus, we a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fransson, Liselotte, dos Santos, Cristiane, Wolbert, Petra, Sjöholm, Åke, Rafacho, Alex, Ortsäter, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905931/
https://www.ncbi.nlm.nih.gov/pubmed/24423471
http://dx.doi.org/10.1186/1758-5996-6-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905931/
https://www.ncbi.nlm.nih.gov/pubmed/24423471
http://dx.doi.org/10.1186/1758-5996-6-3

Ejemplares similares